Carlos Vilches

7.3k total citations · 2 hit papers
132 papers, 5.6k citations indexed

About

Carlos Vilches is a scholar working on Immunology, Epidemiology and Oncology. According to data from OpenAlex, Carlos Vilches has authored 132 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Immunology, 23 papers in Epidemiology and 13 papers in Oncology. Recurrent topics in Carlos Vilches's work include Immune Cell Function and Interaction (89 papers), T-cell and B-cell Immunology (85 papers) and Immunotherapy and Immune Responses (20 papers). Carlos Vilches is often cited by papers focused on Immune Cell Function and Interaction (89 papers), T-cell and B-cell Immunology (85 papers) and Immunotherapy and Immune Responses (20 papers). Carlos Vilches collaborates with scholars based in Spain, United Kingdom and United States. Carlos Vilches's co-authors include Peter Parham, Natalia Gómez‐Lozano, Miguel López‐Botet, Aura Muntasell, Ana Angulo, Núria Malats, Mónica Gumá, Clair M. Gardiner, Rosario de Pablo and Manuela Moraru and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Carlos Vilches

129 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

KIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive Immunity

2002 780 citations Carlos Vilches, Peter Parham profile →
Imprint of human cytomegalovirus infection on the NK cell receptor repertoire

2004 664 citations Carlos Vilches, Natalia Gómez‐Lozano et al. profile →

Peers

Countries citing papers authored by Carlos Vilches

Since Specialization

Citations

This map shows the geographic impact of Carlos Vilches's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Vilches with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Vilches more than expected).

Fields of papers citing papers by Carlos Vilches

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Vilches. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Vilches. The network helps show where Carlos Vilches may publish in the future.

Co-authorship network of co-authors of Carlos Vilches

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Vilches. A scholar is included among the top collaborators of Carlos Vilches based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Vilches. Carlos Vilches is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hemizygous Amplification and Sanger Sequencing of HLA‐B35:433* From an Umbilical‐Cord Blood Sample 2025 ·HLA ·(unknown), Sofía Garrido, (unknown), Carlos Vilches, (unknown)	0
2	Alloreactive adaptive natural killer cells in renal transplantation: Potential contribution to allograft microvascular inflammation 2025 ·American Journal of Transplantation ·Elisenda Alari‐Pahissa, (unknown), (unknown), Anna Buxeda, (unknown), (unknown), José Yélamos, (unknown), (unknown), Marta Riera, Carla Burballa, (unknown), María José Pérez‐Sáez, Dolores Redondo‐Pachón, Carlos Vilches, Marta Crespo, Miguel López‐Botet	0
3	NKG2C Sequence Polymorphism Modulates the Expansion of Adaptive NK Cells in Response to Human CMV 2024 ·HLA ·(unknown), Manuela Moraru, (unknown), (unknown), Aura Muntasell, Miguel López‐Botet, Carlos Vilches	1
4	Microvascular inflammation in the absence of human leukocyte antigen-donor-specific antibody and C4d: An orphan category in Banff classification with cytotoxic T and natural killer cell infiltration 2023 ·American Journal of Transplantation ·Anna Buxeda, Laura Llinàs-Mallol, Javier Gimeno, Dolores Redondo‐Pachón, Carlos Arias-Cabrales, Carla Burballa, (unknown), Miguel López‐Botet, José Yélamos, Carlos Vilches, Maarten Naesens, María José Pérez‐Sáez, Julio Pascual, Marta Crespo	16
5	Long-Term Evolution of the Adaptive NKG2C+ NK Cell Response to Cytomegalovirus Infection in Kidney Transplantation: An Insight on the Diversity of Host–Pathogen Interaction 2021 ·The Journal of Immunology ·(unknown), Dolores Redondo‐Pachón, Laura Llinàs-Mallol, José Yélamos, Elisenda Alari‐Pahissa, María José Pérez‐Sáez, (unknown), Dàlia Raϊch‐Regué, Carlos Vilches, Julio Pascual, Marta Crespo, Miguel López‐Botet	9
6	Pretransplant adaptive NKG2C+ NK cells protect against cytomegalovirus infection in kidney transplant recipients 2019 ·American Journal of Transplantation ·(unknown), Dolores Redondo‐Pachón, Laura Llinàs-Mallol, José Yélamos, (unknown), María José Pérez‐Sáez, Joan Vila, Marcel Costa-García, Dàlia Raϊch‐Regué, Carlos Vilches, Julio Pascual, Marta Crespo, Miguel López‐Botet	19
7	Relationship of NKG2C Copy Number with the Distribution of Distinct Cytomegalovirus-Induced Adaptive NK Cell Subsets 2016 ·The Journal of Immunology ·Aura Muntasell, (unknown), Elisa Cisneros, Andrea Vera, Manuela Moraru, Carlos Vilches, Miguel López‐Botet	61
8	Adaptive NKG2C+ NK Cell Response and the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients 2016 ·The Journal of Immunology ·Dolores Redondo‐Pachón, Marta Crespo, José Yélamos, Aura Muntasell, María José Pérez‐Sáez, Sílvia Pérez-Fernández, Joan Vila, Carlos Vilches, Julio Pascual, Miguel López‐Botet	53
9	Antibody-Mediated Response of NKG2Cbright NK Cells against Human Cytomegalovirus 2015 ·The Journal of Immunology ·Marcel Costa-García, Andrea Vera, Manuela Moraru, Carlos Vilches, Miguel López‐Botet, Aura Muntasell	91
10	Increased Risk of Severe Hepatitis C Virus Recurrence After Liver Transplantation in Patients With a T Allele of IL28B rs12979860 2012 ·Transplantation ·Elisa Cisneros, (unknown), María Jesús Citores, (unknown), Clara Salas, Ana García‐Noblejas, M. Carmen Cañizares, (unknown), Valentín Cuervas‐Mons, Carlos Vilches	19
11	Genetic Basis of End-Stage Hypertrophic Cardiomyopathy 2011 ·European Journal of Heart Failure ·Pablo García‐Pavía, María Eugenia Vázquez, Javier Segovia, Clara Salas, (unknown), Manuel Gómez‐Bueno, Carlos Vilches, M. Esther Gallardo, Rafael Garesse, Jesús Molano, Belén Bornstein, Luis Alonso-Pulpón	48
12	Mitochondrial haplogroups associated with end-stage heart failure and coronary allograft vasculopathy in heart transplant patients 2011 ·European Heart Journal ·M. Esther Gallardo, Pablo García‐Pavía, Rodrigo Chamorro, María Eugenia Vázquez, Manuel Gómez‐Bueno, I. Millán, Berta Almoguera, (unknown), Javier Segovia, Carlos Vilches, Luis Alonso-Pulpón, Rafael Garesse, Belén Bornstein	23
13	Duplication, mutation and recombination of the human orphan gene KIR2DS3 contribute to the diversity of KIR haplotypes 2008 ·Genes and Immunity ·(unknown), A. Meenagh, Natalia Gómez‐Lozano, (unknown), Derek Middleton, Carlos Vilches	41
14	An apparent KIR2DS2‐negative KIR2DL2‐positive genotype discloses the novel allele KIR2DS200104* 2007 ·Tissue Antigens ·Natalia Gómez‐Lozano, Carlos Vilches	2
15	Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002 2003 ·Immunogenetics ·Steven G. E. Marsh, Peter Parham, Bo Dupont, Daniel E. Geraghty, John Trowsdale, Derek Middleton, Carlos Vilches, Mary Carrington, Campbell S. Witt, Lisbeth A. Guethlein, Heather Shilling, (unknown), Katharine C. Hsu, Hester Wain	84
16	Complementary DNA sequence of the novel HLA‐B3704 allele 2002 ·Tissue Antigens* ·E. Estefanía, Natalia Gómez‐Lozano, Rosario de Pablo, E. Moreno, Carlos Vilches	8
17	Different NK Cell Surface Phenotypes Defined by the DX9 Antibody Are Due to KIR3DL1 Gene Polymorphism 2001 ·The Journal of Immunology ·Clair M. Gardiner, Lisbeth A. Guethlein, Heather Shilling, Marcelo J. Pando, William H. Carr, Raja Rajalingam, Carlos Vilches, Peter Parham	217
18	KIR2DL5, a Novel Killer-Cell Receptor with a D0-D2 Configuration of Ig-Like Domains 2000 ·The Journal of Immunology ·Carlos Vilches, Raja Rajalingam, Markus Uhrberg, Clair M. Gardiner, Neil T. Young, Peter Parham	91
19	Diversity of HLA‐B61 alleles and haplotypes in East Asians and Spanish Gypsies 1998 ·Tissue Antigens ·Atsuko Ogawa, Katsushi Tokunaga, Longshan Lin, Koichi Kashiwase, Hidenori Tanaka, María José Herrero, Carlos Vilches, (unknown), (unknown), Nyam‐Osor Chimge, (unknown), (unknown), Tatsuya Akaza, Kenji Tadokoro, Takeo Juji	13
20	Distribution of HLA antigens in Spanish Gypsies: A comparative study 1992 ·Tissue Antigens ·Rosario de Pablo, Carlos Vilches, E. Moreno, (unknown), (unknown), M. Kreisler	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact